RWA
GWPH

River Wealth Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

River Wealth Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-150
Closed -$15K – 544
2018
Q4 		$15K Sell
150
-100
-40% -$13.1K 0.01% 374
2018
Q3 		$43K Buy
+250
New +$36.1K 0.02% 292

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

River Wealth Advisors's GWPH Position: Q1 2019 in Review

River Wealth Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2019, closing a stake of 150 shares — an estimated $15K sold.

River Wealth Advisors first reported a position in GWPH in Q3 2018 and held it in 2 quarters. The position peaked at $43K in Q3 2018. 320 funds tracked by Wall St. Rank hold GWPH as of Q1 2019.

  • River Wealth Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2019 after selling out during the quarter.
  • River Wealth Advisors sold 150 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2019, an estimated $15K.
  • River Wealth Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2018 and held it in 2 quarters.
  • River Wealth Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $43K in Q3 2018.
  • 320 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2019.

Based on River Wealth Advisors's 13F filing for Q1 2019, filed 7 May 2019.